What is Azitra Inc?
, an early-stage clinical biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and topical live biotherapeutic products to treat skin diseases in the United States.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, an early-stage clinical biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and topical live biotherapeutic products to treat skin diseases in the United States. The company develops ATR-04, a genetically modified strain of S. The company is listed on the AMEX in USA, operating in the Healthcare sector, with a market capitalisation of 3.13M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.